Mitsubishi UFJ Asset Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-183,126
| Closed | -$1.67M | – | 1187 |
|
2022
Q1 | $1.67M | Sell |
183,126
-6,719
| -4% | -$61.1K | 0.01% | 767 |
|
2021
Q4 | $3.97M | Sell |
189,845
-62,834
| -25% | -$1.31M | 0.02% | 627 |
|
2021
Q3 | $6.46M | Sell |
252,679
-14,212
| -5% | -$363K | 0.03% | 502 |
|
2021
Q2 | $9.33M | Sell |
266,891
-24,429
| -8% | -$854K | 0.05% | 399 |
|
2021
Q1 | $9.7M | Buy |
291,320
+197,695
| +211% | +$6.59M | 0.06% | 347 |
|
2020
Q4 | $2.43M | Sell |
93,625
-15,047
| -14% | -$390K | 0.02% | 621 |
|
2020
Q3 | $1.07M | Buy |
108,672
+7,264
| +7% | +$71.7K | 0.01% | 710 |
|
2020
Q2 | $350K | Buy |
101,408
+28,338
| +39% | +$97.8K | ﹤0.01% | 803 |
|
2020
Q1 | $224K | Buy |
73,070
+3,017
| +4% | +$9.25K | ﹤0.01% | 839 |
|
2019
Q4 | $368K | Buy |
70,053
+27,793
| +66% | +$146K | ﹤0.01% | 810 |
|
2019
Q3 | $218K | Buy |
42,260
+886
| +2% | +$4.57K | ﹤0.01% | 821 |
|
2019
Q2 | $250K | Buy |
41,374
+11,069
| +37% | +$66.9K | ﹤0.01% | 806 |
|
2019
Q1 | $219K | Buy |
30,305
+733
| +2% | +$5.3K | ﹤0.01% | 784 |
|
2018
Q4 | $216K | Buy |
+29,572
| New | +$216K | 0.01% | 748 |
|